(Q44361841)

English

Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Luis Bautista

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Christine Bugos

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

George Dirnberger

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tracy Atherton

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

194-209

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence and health burden of self-reported diabetes in older Mexican Americans: findings from the Hispanic established populations for epidemiologic studies of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms and well-being in relation to glycemic control in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term glycemic control relates to mortality in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical profile of glimepiride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of conventional sulfonylureas and glimepiride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Repaglinide versus glyburide: a one-year comparison trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Country of birth, acculturation status and abdominal obesity in a national sample of Mexican-American women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintaining long-term control of blood pressure: the role of improved compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)90025-7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44361841&oldid=2019822107"